Status
Conditions
Treatments
About
The present study aims to increase Veteran access to supervised exercise therapy and expand its role in improving functional status, quality of life, and cardiovascular risk profile of Veterans with PAD.
Full description
The investigators will use the VA Telehealth service to deploy a remotely accessible supervised exercise training program and evaluate whether a telehealth-based intervention can improve walking performance, quality of life, and ultimately cardiac risk in Veterans with PAD. The impetus for the current proposal stems from the following: 1) over 50% of VA-enrolled Veterans live in rural communities; 2) Veterans with PAD are older (mean age, 70 years), further increasing their risk for functional decline; and 3) there is a significant lack of access to facility-based supervised exercise training for Veterans with PAD. The objectives include the following:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of PAD, defined as a history of an ankle-brachial index (ABI) of 0.90, prior revascularization of a lower limb for symptomatic disease more than 30 days prior to presentation, or ABI >0.90 with evidence of PAD based on noninvasive vascular laboratory testing or angiography
In addition, participants will require access to cellular signal at place of residence and/or exercise location
Exclusion criteria
Justification for exclusion criteria centers on inability to safely participate in the remote intervention. Specific exclusion criteria includes the following:
major lower extremity amputation
critical limb ischemia
inability to ambulate without a walker or wheelchair
significant visual or hearing impairment
individuals whose function is limited by severe conditions such as severe ischemic heart disease or > Class II NYHA heart failure
individuals capable of ambulating at a level comparable to the amount of exercise to be prescribed at baseline
individuals currently enrolled in another exercise trial or cardiac rehab program
individuals with uncontrolled psychiatric illness or dementia
categorically vulnerable
Primary purpose
Allocation
Interventional model
Masking
73 participants in 2 patient groups
Loading...
Central trial contact
Jorge A Gutierrez, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal